Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

170.59
-0.1500-0.09%
Post-market: 170.770.1800+0.11%17:45 EDT
Volume:8.96M
Turnover:1.53B
Market Cap:410.84B
PE:18.28
High:172.18
Open:169.91
Low:169.68
Close:170.74
Loading ...

3 strong ASX ETFs to buy for simple investing

MotleyFool
·
27 Jul

How Johnson & Johnson Stock (JNJ) Discovered a New Lease of Life

TIPRANKS
·
26 Jul

Johnson & Johnson Releases Transcript of 2025 Second-Quarter Earnings Conference Call

Reuters
·
26 Jul

US FDA says J&J's Ethicon issues correction related to surgical stapler

Reuters
·
25 Jul

US FDA: There Has Been One Reported Death & One Injury Related to Inadvertent Lockout During Surgical Procedures of Endopath Echelon

THOMSON REUTERS
·
25 Jul

Johnson & Johnson to Participate in Upcoming Wells Fargo Healthcare Conference

Reuters
·
25 Jul

Johnson & Johnson Unveils Promising Data from Alzheimer's Research, Highlighting Anti-Tau Advancements at AAIC 2025

Reuters
·
24 Jul

Halozyme says EU approves new indication for Janssen’s Darzalex Faspro

TIPRANKS
·
23 Jul

Johnson & Johnson Unit Says EC Approved Indication Extension of Imbruvica in Blood Cancer

MT Newswires Live
·
23 Jul

BRIEF-European Commission Approves J&J's Imbruvica As First Targeted Therapy For Some Patients With Untreated Mantle Cell Lymphoma

Reuters
·
23 Jul

BRIEF-European Commission Approves J&J's Darzalex As First Treatment For Patients With High-Risk Smouldering Multiple Myeloma

Reuters
·
23 Jul

J&J: Ec Approves Imbruvica as First Targeted Therapy for Some Patients With Previously Untreated Mantle Cell Lymphoma

THOMSON REUTERS
·
23 Jul

European Commission Approves Darzalex® (Daratumumab) as the First Licensed Treatment for Patients With High-Risk Smouldering Multiple Myeloma

THOMSON REUTERS
·
23 Jul

Johnson & Johnson upgraded to Buy from Hold at Erste Group

TIPRANKS
·
23 Jul

Boston Scientific lifts annual profit view on steady heart devices demand

Reuters
·
23 Jul

Stockland Corporation Nears Completion of $2 Billion MPark Innovation Precinct in Macquarie Park

Reuters
·
23 Jul

Johnson & Johnson MedTech and Pacira BioSciences Announce Strategic Partnership to Enhance Osteoarthritis Knee Care

Reuters
·
22 Jul

Johnson & Johnson Reports Strong Earnings Growth

TIPRANKS
·
22 Jul

Johnson & Johnson Stock (JNJ) Bulls Target Breakout Despite Looming Patent Cliff

TIPRANKS
·
22 Jul

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

Reuters
·
22 Jul